Search research articles
Contact Us
Filters
Showing results (1-10 of 23) with videos related to
Page
of 3
Sort By:
International Review of Psychiatry (Abingdon, England)
|
February 21, 2025
Learning how to make use of dissociative therapies
David S Mathai
Frontiers in Psychology
|
April 11, 2022
Toward Synergies of Ketamine and Psychotherapy
David S Mathai, Victoria Mora, Albert Garcia-Romeu
Journal of Affective Disorders
|
May 29, 2024
At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data
David S Mathai, Thomas D Hull, Leonardo Vando, et al.
Scientific Reports
|
November 14, 2024
Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals
Erin Wang, David S Mathai, Natalie Gukasyan, et al.
Journal of Affective Disorders
|
February 15, 2020
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review
David S Mathai, Matthew J Meyer, Eric A Storch, et al.
Psychopharmacology
|
February 2, 2023
Reconsidering "dissociation" as a predictor of antidepressant efficacy for esketamine
David S Mathai, Sandeep M Nayak, David B Yaden, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 18, 2019
Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys
Christopher D Verrico, David S Mathai, Hong Gu, et al.
The American Journal on Addictions
|
October 18, 2016
"Just one bad high:" considering synthetic cannabinoid outcome expectancies in adolescents
David S Mathai, Christopher D Verrico, Daryl Shorter, et al.
Expert Review of Neurotherapeutics
|
July 21, 2020
Deep transcranial magnetic stimulation for obsessive compulsive disorder
Alexis G McCathern, David S Mathai, Raymond Y Cho, et al.
Journal of Affective Disorders
|
June 26, 2022
Mapping consent practices for outpatient psychiatric use of ketamine
David S Mathai, Scott M Lee, Victoria Mora, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 23) with videos related to
Sort By:
Page
of 3
International Review of Psychiatry (Abingdon, England)
|
February 21, 2025
Learning how to make use of dissociative therapies
David S Mathai
Frontiers in Psychology
|
April 11, 2022
Toward Synergies of Ketamine and Psychotherapy
David S Mathai, Victoria Mora, Albert Garcia-Romeu
Journal of Affective Disorders
|
May 29, 2024
At-home, telehealth-supported ketamine treatment for depression: Findings from longitudinal, machine learning and symptom network analysis of real-world data
David S Mathai, Thomas D Hull, Leonardo Vando, et al.
Scientific Reports
|
November 14, 2024
Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals
Erin Wang, David S Mathai, Natalie Gukasyan, et al.
Journal of Affective Disorders
|
February 15, 2020
The relationship between subjective effects induced by a single dose of ketamine and treatment response in patients with major depressive disorder: A systematic review
David S Mathai, Matthew J Meyer, Eric A Storch, et al.
Psychopharmacology
|
February 2, 2023
Reconsidering "dissociation" as a predictor of antidepressant efficacy for esketamine
David S Mathai, Sandeep M Nayak, David B Yaden, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 18, 2019
Recovery from impaired working memory performance during chronic Δ-9-tetrahydrocannabinol administration to adolescent rhesus monkeys
Christopher D Verrico, David S Mathai, Hong Gu, et al.
The American Journal on Addictions
|
October 18, 2016
"Just one bad high:" considering synthetic cannabinoid outcome expectancies in adolescents
David S Mathai, Christopher D Verrico, Daryl Shorter, et al.
Expert Review of Neurotherapeutics
|
July 21, 2020
Deep transcranial magnetic stimulation for obsessive compulsive disorder
Alexis G McCathern, David S Mathai, Raymond Y Cho, et al.
Journal of Affective Disorders
|
June 26, 2022
Mapping consent practices for outpatient psychiatric use of ketamine
David S Mathai, Scott M Lee, Victoria Mora, et al.
Page
of 3